Arylamine N-Acetyltransferases from mycobacteria: investigations of a potential yarget for anti-tubercular therapy

Arylamine N-Acetyltransferases from mycobacteria: investigations of a potential yarget for anti-tubercular therapy

<p>Reactivation of latent infection is the major cause of tuberculosis (TB). Cholesterol is a critical carbon source during latent infection. Catabolism of cholesterol contributes to the pool of propionyl-CoA, a precursor that is incorporated into cell-wall lipids.</p> <p>Arylamine...

Szczegółowa specyfikacja

Opis bibliograficzny
1. autor:	Abuhammad, A
Kolejni autorzy:	Sim, E
Format:	Praca dyplomowa
Język:	English
Wydane:	2013
Hasła przedmiotowe:	Pharmacology Medical sciences

Podobne zapisy

Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
od: Westwood, I, i wsp.
Wydane: (2010)

Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophages
od: Abuhammad, A, i wsp.
Wydane: (2012)

Investigating the endogenous role of human n-acetyltransferase 1, as potential breast cancer biomarker, using chemical biology
od: Laurieri, N
Wydane: (2012)

Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophages.
od: Areej Abuhammad, i wsp.
Wydane: (2012-01-01)

Structural Studies on the Mycobacterial Arylamine N-Acetyltransferases
od: Abuhammad, A, i wsp.
Wydane: (2010)

The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
od: Sandy, J, i wsp.
Wydane: (2002)

Analysis of β-amino alcohols as inhibitors of the potential anti-tubercular target N-acetyltransferase.
od: Fullam, E, i wsp.
Wydane: (2011)

Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.
od: Fullam, E, i wsp.
Wydane: (2009)

Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.
od: Abuhammad, A, i wsp.
Wydane: (2010)

Mapping the genes for arylamine N-acetyltransferases
od: Fakis, G
Wydane: (2000)

Structure and mechanism of arylamine N-acetyltransferases.
od: Westwood, I, i wsp.
Wydane: (2006)

Arylamine N-acetyltransferase in adult mouse brain
od: Mo, M, i wsp.
Wydane: (2004)

Expression of the genes for arylamine N-acetyltransferases in mice
od: Boukouvala, S, i wsp.
Wydane: (2002)

Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
od: Kawamura, A, i wsp.
Wydane: (2003)

Neuroendocrine expression of mouse arylamine N-acetyltransferase 2
od: Wakefield, L, i wsp.
Wydane: (2006)

Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
od: Sim, E, i wsp.
Wydane: (2008)

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.
od: Russell, A, i wsp.
Wydane: (2009)

Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
od: Laurieri, N, i wsp.
Wydane: (2014)

Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
od: Kawamura, A, i wsp.
Wydane: (2005)

An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
od: Brooke, E, i wsp.
Wydane: (2003)

Arylamine N-acetyltransferase expression during murine heart development
od: Wakefield, L, i wsp.
Wydane: (2004)

Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population
od: Hiba Chelouti, i wsp.
Wydane: (2017-08-01)

Biochemical Characterization of Arylamine N-acetyltransferases From Vibrio vulnificus
od: Xinning Liu, i wsp.
Wydane: (2021-01-01)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris.
od: Madikane, V, i wsp.
Wydane: (2007)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris
od: Madikane, V, i wsp.
Wydane: (2007)

Protein-ligand interactions of arylamine N-acetyltransferase from Mycobacterium smegmatis
od: Brooke, E
Wydane: (2003)

Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer
od: Amjad Mahasneh, i wsp.
Wydane: (2012-01-01)

Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
od: Raúl A. Salazar-González, i wsp.
Wydane: (2022-01-01)

Hamster arylamine N-acetyltransferase 2: Investigation of substrate specificity by high-through-put screening
od: Kawamura, A, i wsp.
Wydane: (2004)

Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.
od: Wang, H, i wsp.
Wydane: (2005)

Distribution of arylamine N-acetyltransferase 2 (NAT2) genotypes among Omanis
od: Musbah O. M. Tanira, i wsp.
Wydane: (2003-04-01)

Humans and Chimpanzees Display Opposite Patterns of Diversity in Arylamine N-Acetyltransferase Genes
od: Christelle Vangenot, i wsp.
Wydane: (2019-07-01)

Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes
od: Mark A. Doll, i wsp.
Wydane: (2017-07-01)

Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG.
od: Anderton, M, i wsp.
Wydane: (2006)

Characterization of the putative operon containing arylamine N−acetyltransferase (nat) in Mycobacterium bovis BCG
od: Eltis, E
Wydane: (2006)

Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversity.
od: Abuhammad, A, i wsp.
Wydane: (2013)

Pathogenic mycobacteria achieve cellular persistence via lipid-mediated inhibition of the Niemann-Pick disease type C pathway
od: Fineran, PD
Wydane: (2014)

Network pharmacology and in silico investigation into the therapeutic potential of phytoconstituents of Peucedanum ostruthium as anti-tubercular agents
od: Neeru Bhanwala, i wsp.
Wydane: (2025-03-01)

Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs).
od: Brooke, E, i wsp.
Wydane: (2003)

Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
od: Westwood, I, i wsp.
Wydane: (2011)